Trial intelligence / Profile preview

Push-Dose Adrenaline for Peri-intubation Hypotension

NCT07620327Phase 4Not yet recruiting

Sponsor
Marmara University Pendik Training and Research Hospital
Start
Jun 2026
Primary completion
Dec 2026
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in hypotension comparing Placebo with Push dose adrenaline (2 arms). Primary endpoint: Peri-intubation hypotension at 60 months. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

epinephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT07620327.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07620327.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call